0001593968-22-000421.txt : 20220208
0001593968-22-000421.hdr.sgml : 20220208
20220208170144
ACCESSION NUMBER: 0001593968-22-000421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220206
FILED AS OF DATE: 20220208
DATE AS OF CHANGE: 20220208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colangelo Dominick
CENTRAL INDEX KEY: 0001313403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 22602436
MAIL ADDRESS:
STREET 1: 1000 WINTER ST.
STREET 2: SUITE 2200
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-02-06
0000887359
Vericel Corp
VCEL
0001313403
Colangelo Dominick
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
true
false
false
President and CEO
Common Stock
2022-02-06
4
M
false
6937
0
A
150170
D
Common Stock
2022-02-06
4
F
false
3049
33.91
D
147121
D
Restricted Stock Unit
2022-02-06
4
M
false
6937
33.91
D
Common Stock
6937
6938
D
The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest on February 6, 2023.
These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units.
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
No expiration date for this type of award.
/s/ Sean Flynn, as Attorney-in-Fact for Dominick C. Colangelo
2022-02-08